Physician profile
David J Sutter
NPI 1144288804
$1,262.90
in general payments reported to CMS, 2019-2025
16 companies · $704 in 2025
The $704 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $272 · 2024: $287 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.85 | 2024-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $166.23 | 2025 | Amvuttra, Onpattro |
| Novartis Pharmaceuticals Corporation | $152.55 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.38 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $143.54 | 2023-2025 | Camzyos |
| Novo Nordisk INC | $62.83 | 2025 | Ozempic, Wegovy |
| Biotronik INC. | $52.90 | 2025 | Pk Papyrus, Acticor 7 Vr-T Dx |
| Esperion Therapeutics, INC. | $51.21 | 2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $50.00 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $43.81 | 2023 | Verquvo |
| Amgen INC. | $40.54 | 2023-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $33.17 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $25.14 | 2025 | |
| Scpharmaceuticals INC. | $22.37 | 2025 | |
| La Jolla Pharmaceutical Company | $21.28 | 2023 | Xerava |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $16.10 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.